Tonix Pharmaceuticals Holding Corp.
TNXP
$37.98
$2.135.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.00% | 23.88% | -55.55% | 81.96% | -427.32% |
| Total Depreciation and Amortization | -103.45% | -49.28% | 90.59% | -63.70% | 39.11% |
| Total Amortization of Deferred Charges | 669.23% | 123.55% | -232.06% | 394.37% | -114.14% |
| Total Other Non-Cash Items | 86.28% | 712.57% | -72.23% | -97.90% | 1,280.20% |
| Change in Net Operating Assets | 325.96% | -151.15% | 196.85% | -237.48% | 313.65% |
| Cash from Operations | 10.53% | -13.32% | 22.18% | -89.55% | 43.56% |
| Capital Expenditure | -8,683.33% | -100.00% | 66.67% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -42,216.67% | -100.00% | 66.67% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -1,268.79% | 0.00% | 0.00% | -200.00% |
| Issuance of Common Stock | -77.70% | -27.65% | 94.46% | 268.73% | 53,960.87% |
| Repurchase of Common Stock | 4.76% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.55% | 31.13% | -47.27% | 52.42% | -- |
| Cash from Financing | -77.81% | -41.83% | 98.47% | 510.75% | 3,413.68% |
| Foreign Exchange rate Adjustments | 55.56% | -137.50% | 241.18% | -1,800.00% | 125.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.38% | -53.31% | 192.99% | 932.28% | 83.84% |